NIHR Maudsley BRC Blog

Our latest news and events

Cognitive flexibility potential new target in treatment resistant schizophrenia

Researchers at King’s College London have found that an important brain mechanism that allows us to switch between thinking about two or more ideas may help treat patients with schizophrenia who do not respond well to current treatments. 

By NIHR Maudsley BRC at 1 Apr 2021

IBS Digital therapeutic Parallel™ developed by King’s researchers gets approval in UK and US

Parallel™ is the first prescription only digital therapeutic to provide cognitive behavioural therapy (CBT)  to adults with irritable bowel syndrome (IBS) to receive the FDA Marketing Authorization in the US.  ParallelTM has also obtained a CE mark and been recommended for Evaluation in Practice by the National Institute for Health and Care Excellence (NICE).

 

By NIHR Maudsley BRC at 1 Apr 2021

COVID-19 pandemic leads to rapid uptake of remote consultations in mental healthcare

Travel and social distancing restrictions due to the COVID-19 pandemic are leading to a significant shift in mental healthcare delivery, as clinicians make the switch from predominantly in-person to remote consultations, a study by King’s College London finds.

 

By NIHR Maudsley BRC at 31 Mar 2021

NIHR welcomes new vision for the Future of UK Clinical Research Delivery

NIHR and partner organisations across the health research ecosystem have this week welcomed the publication of a bold and ambitious vision for the future of clinical research delivery in the UK.

 

By NIHR Maudsley BRC at 25 Mar 2021

Novavax confirms vaccine provides 100% protection against severe COVID-19

Final analysis of UK Phase 3 trials of Novavax's COVID-19 vaccine reveals it provides 100% protection against severe COVID-19.

By NIHR Wellcome King's Clinical Research Facility at 16 Mar 2021